CNBC October 1, 2020
Christina Farr

Key Points

– Hims is a direct-to-consumer company selling health products and services targeted at millennials.

– The company, which operates both men’s and women’s brands and is sometimes called Hims & Hers, will raise $280 million through a merger with a SPAC sponsored by Oaktree Capital Management.

– Once the transaction is completed, the company will be traded on NYSE under the symbol “HIMS.”

Hims, Inc., a direct-to-consumer company that sells health products and services targeted at millennials, is going public just three years after it got its start.

The company, which operates both men’s and women’s health brands and is sometimes called Hims & Hers, is merging with a special purpose acquisition company (SPAC) sponsored by investment...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Health IT, Investments, Patient / Consumer, Technology, Telehealth, Trends
AI Startups: Google DeepMind CEO’s Startup Raises $600 Million
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
AI-Drug Design & Medical Education Score Massive Rounds | StartUp Health Insights: Week of Apr 1, 2025
JPMorgan’s Health Unit To Invest In Small Business Health Plans
An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025

Share This Article